Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1995;92:2087-2094

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schächinger, V.
Right arrow Articles by Zeiher, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schächinger, V.
Right arrow Articles by Zeiher, A. M.

(Circulation. 1995;92:2087-2094.)
© 1995 American Heart Association, Inc.


Articles

Quantitative Assessment of Coronary Vasoreactivity in Humans In Vivo

Importance of Baseline Vasomotor Tone in Atherosclerosis

Volker Schächinger, MD; Andreas M. Zeiher, MD

From the Department of Internal Medicine IV, J.W. Goethe-University, Frankfurt, Germany.

Correspondence to Dr V. Schächinger, Division of Cardiology, Department of Internal Medicine IV, J.W. Goethe-University, Theodor-Stern-Kai 7, D-60590 Frankfurt, Germany.

Background Disturbances in vasomotor tone are closely linked to the development of atherosclerosis and play an integral part in the pathophysiology of myocardial ischemia in patients with coronary artery disease. Currently, evaluation of coronary vasomotor tone relies on assessment of luminal changes in response to vasoactive stimuli by quantitative angiography. Assessment of luminal changes, however, may be misleading because of the effects of geometric magnification induced by atherosclerotic wall thickening and differences in basal tone, which may obscure potential effects of vasoactive stimuli.

Methods and Results Combining angiographic measurements of luminal changes with measurements of coronary wall architecture determined by intracoronary ultrasound, we calculated absolute coronary arterial vasomotor tone in 34 patients with angiographically normal or "minimally diseased" coronary arteries. Epicardial artery vasodilator capacity in response to intracoronary nitroglycerin decreased significantly with increasing atherosclerotic wall thickening. An inverse relation existed between local atherosclerotic plaque load and nitroglycerin-induced changes in vasomotor tone (r=-.65, P<.0001) regardless of potential systematically operative factors. At the same time, basal vasomotor tone significantly decreased with increasing local atherosclerotic wall thickening (r=-.38, P=.004). The vasomotor effects of acetylcholine, an endothelium-dependent vasodilator, were inversely related to wall thickening only in segments with very minor degrees of atherosclerosis, whereas no such relation was observed for epicardial artery segments with more advanced atherosclerotic wall thickening. In these segments, however, vasoreactivity to acetylcholine was closely correlated with basal vasomotor tone (r=-.62, P=.0002).

Conclusions Atherosclerosis is associated with impairment of the vasodilator response to both nitroglycerin and acetylcholine in epicardial arteries in vivo. Basal vasomotor tone appears to be the primary determinant of the altered coronary vasoreactivity in response to vasoactive stimuli.


Key Words: coronary disease • vasomotor tone • acetylcholine • ultrasonics • atherosclerosis




This article has been cited by other articles:


Home page
Eur Heart JHome page
T. F. Luscher, M. Pieper, M. Tendera, M. Vrolix, W. Rutsch, F. van den Branden, R. Gil, K.-O. Bischoff, M. Haude, D. Fischer, et al.
A randomized placebo-controlled study on the effect of nifedipine on coronary endothelial function and plaque formation in patients with coronary artery disease: the ENCORE II study
Eur. Heart J., July 1, 2009; 30(13): 1590 - 1597.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
T. Ashikaga, M. Nishizaki, H. Fujii, K. Ihara, S. Niki, T. Murai, S. Maeda, N. Yamawake, Y. Kishi, and M. Isobe
Coronary Endothelial Dysfunction and Impaired Microcirculation Response to Atrial Natriuretic Peptide in Hyperinsulinemia
Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2008; 13(1): 58 - 63.
[Abstract] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. R. Willoughby, S. Stewart, A. S. Holmes, Y. Y. Chirkov, and J. D. Horowitz
Platelet Nitric Oxide Responsiveness: A Novel Prognostic Marker in Acute Coronary Syndromes
Arterioscler Thromb Vasc Biol, December 1, 2005; 25(12): 2661 - 2666.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
N. P. Johnson and K. L. Gould
Clinical Evaluation of a New Concept: Resting Myocardial Perfusion Heterogeneity Quantified by Markovian Analysis of PET Identifies Coronary Microvascular Dysfunction and Early Atherosclerosis in 1,034 Subjects
J. Nucl. Med., September 1, 2005; 46(9): 1427 - 1437.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
The ENCORE Investigators*
Effect of Nifedipine and Cerivastatin on Coronary Endothelial Function in Patients With Coronary Artery Disease: The ENCORE I Study (Evaluation of Nifedipine and Cerivastatin On Recovery of coronary Endothelial function)
Circulation, January 28, 2003; 107(3): 422 - 428.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
S. Simula, E. Vanninen, L. Viitanen, A. Kareinen, S. Lehto, P. Pajunen, M. Syvanne, J. Kuikka, M. Laakso, and J. Hartikainen
Cardiac Adrenergic Innervation Is Affected in Asymptomatic Subjects with Very Early Stage of Coronary Artery Disease
J. Nucl. Med., January 1, 2002; 43(1): 1 - 7.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Y. Y. Chirkov, A. S. Holmes, S. R. Willoughby, S. Stewart, R. D. Wuttke, P. R. Sage, and J. D. Horowitz
Stable angina and acute coronary syndromes are associated with nitric oxide resistance in platelets
J. Am. Coll. Cardiol., June 1, 2001; 37(7): 1851 - 1857.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
W. J. Kop, D. S. Krantz, R. H. Howell, M. A. Ferguson, V. Papademetriou, D. Lu, J. J. Popma, J. F. Quigley, M. Vernalis, and J. S. Gottdiener
Effects of mental stress on coronary epicardial vasomotion and flow velocity in coronary artery disease: relationship with hemodynamic stress responses
J. Am. Coll. Cardiol., April 1, 2001; 37(5): 1359 - 1366.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
V. Schachinger, M.B. Britten, S. Dimmeler, and A.M. Zeiher
NADH/NADPH oxidase p22 phox gene polymorphism is associated with improved coronary endothelial vasodilator function
Eur. Heart J., January 1, 2001; 22(1): 96 - 101.
[Abstract] [PDF]


Home page
CirculationHome page
V. Schächinger, M. B. Britten, and A. M. Zeiher
Prognostic Impact of Coronary Vasodilator Dysfunction on Adverse Long-Term Outcome of Coronary Heart Disease
Circulation, October 3, 2000; (2000) 0.
[Abstract] [Full Text]


Home page
CirculationHome page
V. Schachinger, M. B. Britten, and A. M. Zeiher
Prognostic Impact of Coronary Vasodilator Dysfunction on Adverse Long-Term Outcome of Coronary Heart Disease
Circulation, April 25, 2000; 101(16): 1899 - 1906.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
D Tousoulis, C Tentolouris, T Crake, C Stefanadis, P Toutouzas, and G Davies
Evidence of partially preserved endothelial dilator function in diseased coronary arteries
Heart, October 1, 1999; 82(4): 471 - 476.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
Q. Liu and J. T. Sylvester
Development of intrinsic tone in isolated pulmonary arterioles
Am J Physiol Lung Cell Mol Physiol, May 1, 1999; 276(5): L805 - L813.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. R. Adams, J. Robinson, R. McCredie, J. P. Seale, K. E. Sorensen, J. E. Deanfield, and D. S. Celermajer
Smooth muscle dysfunction occurs independently of impaired endothelium-dependent dilation in adults at risk of atherosclerosis
J. Am. Coll. Cardiol., July 1, 1998; 32(1): 123 - 127.
[Abstract] [Full Text] [PDF]